MEDPACE HOLDINGS INC•Financial Summary•AI-Powered Insights

MEDPACE HOLDINGS INC 2025 Q4
Earnings Overview & AI Insights

Detailed performance report for MEDPACE HOLDINGS INC covering Q4 2025. Gain clarity on earnings, revenue trends, and AI-enhanced strategic analysis.

MEDPACE HOLDINGS INC (2025 Q4)

Earnings Performance

No Performance Data

Summary of Financial Performance: Medpace Holdings, Inc. reported strong financial performance for 2025, with revenue reaching $2.53 billion, a 20% increase from 2024. The fourth quarter revenue was $708.5 million, up 32% year-over-year. EBITDA for the full year was $557.7 million, a 16.1% increase from the prior year, with an EBITDA margin of 22%. Net income for 2025 rose to $451.1 million, up 11.6% from 2024, translating to a net income per diluted share of $15.28.

Company Outlook & Strategy: For 2026, Medpace projects revenue between $2.755 billion and $2.855 billion, representing growth of 8.9% to 12.8%. EBITDA is expected to be between $605 million and $635 million, with net income ranging from $487 million to $511 million. The company plans for mid to high single-digit headcount growth to support this outlook.

Key Industry Trends: The company did not explicitly discuss broader industry trends or external factors during the call.

Operational Highlights: Medpace experienced elevated backlog cancellations in Q4 but maintained a net book-to-bill ratio of 1.04 due to a strong backlog conversion rate of 23.6%. The ending backlog for the year was approximately $3 billion, with $1.9 billion expected to convert to revenue in the next twelve months.

Challenges & Risks: The company noted elevated backlog cancellations as a concern but does not expect this trend to continue into the future. The impact on EBITDA margins due to higher reimbursable cost activity was also highlighted as a challenge.

Key Analyst Questions & Responses: Analysts inquired about revenue growth excluding pass-throughs and headcount growth expectations for 2026. Medpace clarified that reimbursable costs are expected to be slightly higher in 2026 and that headcount growth will accelerate compared to 2025 levels, aiming for mid to high single-digit growth.

Earnings Call Transcript

Access the official earnings call transcript for MEDPACE-HOLDINGS-INC 2025 Q4. It provides valuable insights into management commentary, performance drivers, and forward-looking guidance directly from the company.